+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cough, Cold and Allergy (Hay Fever) Remedies in Mexico

  • PDF Icon

    Report

  • 26 Pages
  • September 2024
  • Region: Mexico
  • Euromonitor International
  • ID: 4424818
Cough, cold and allergy (hay fever) remedies is set to maintain double-digit retail current value growth in Mexico in 2024. In Mexico there has been a change in attitude regarding taking antibiotics, because there is greater awareness of the overuse of these medications, and the antibiotic resistance that this can cause.

The Cough, Cold and Allergy (Hay Fever) Remedies in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Increasing use of OTC medications due to a move away from antibiotics
  • Zero sugar products increasing in cough remedies
  • High levels of environmental pollution increase demand for allergy remedies and nasal decongestants
PROSPECTS AND OPPORTUNITIES
  • Increasing awareness of respiratory health set to drive growth
  • Improved formulations, and an increasing number of natural and organic products
  • Search for innovation to differentiate from the competition
CATEGORY DATA
  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
  • Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
  • Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
  • Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN MEXICO
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources